BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34471508)

  • 1. Emicizumab in acquired haemophilia A: about two clinical cases and literature review.
    Hansenne A; Hermans C
    Ther Adv Hematol; 2021; 12():20406207211038193. PubMed ID: 34471508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of acquired haemophilia A in severe Covid-19: Haemostatic bridging with emicizumab to keep the balance between bleeding and thrombosis.
    Gelbenegger G; Traby L; Rahimi N; Knöbl P
    Br J Clin Pharmacol; 2023 Feb; 89(2):908-913. PubMed ID: 36369653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience.
    Chen EC; Gibson W; Temoczko P; Connell NT; Handin R; Parnes AD
    Haemophilia; 2023 Jan; 29(1):84-89. PubMed ID: 36163651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emicizumab for acquired haemophilia A: A case series.
    Engelen MM; Vandesande J; De Bent J; Van Laer C; Labarque V; Jacquemin M; Peerlinck K; Hermans C; Verhamme P; Vanassche T
    Haemophilia; 2023 Jul; 29(4):1049-1055. PubMed ID: 37276345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emicizumab as first-line therapy in acquired hemophilia A.
    Iarossi M; Hermans C
    Res Pract Thromb Haemost; 2024 May; 8(4):102438. PubMed ID: 38953052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A.
    Al-Banaa K; Gallastegui-Crestani N; von Drygalski A
    Eur J Case Rep Intern Med; 2021; 8(11):002984. PubMed ID: 34912741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emicizumab for the treatment of acquired hemophilia A.
    Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR
    Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
    Pipe SW; Shima M; Lehle M; Shapiro A; Chebon S; Fukutake K; Key NS; Portron A; Schmitt C; Podolak-Dawidziak M; Selak Bienz N; Hermans C; Campinha-Bacote A; Kiialainen A; Peerlinck K; Levy GG; Jiménez-Yuste V
    Lancet Haematol; 2019 Jun; 6(6):e295-e305. PubMed ID: 31003963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group.
    Pfrepper C; Klamroth R; Oldenburg J; Holstein K; Eichler H; Hart C; Moehnle P; Schilling K; Trautmann-Grill K; Alrifai M; Ay C; Miesbach W; Knoebl P; Tiede A
    Hamostaseologie; 2023 Dec; ():. PubMed ID: 38049124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature.
    Thomas VM; Abou-Ismail MY; Lim MY
    Haemophilia; 2022 Jan; 28(1):4-17. PubMed ID: 34820989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired Hemophilia A: An Update on the Etiopathogenesis, Diagnosis, and Treatment.
    Zanon E
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis.
    Batsuli G; Zimowski KL; Tickle K; Meeks SL; Sidonio RF
    Haemophilia; 2019 Sep; 25(5):789-796. PubMed ID: 31373431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emicizumab: Review of the literature and critical appraisal.
    Rodriguez-Merchan EC; Valentino LA
    Haemophilia; 2019 Jan; 25(1):11-20. PubMed ID: 30431213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emicizumab Use in Treatment of Acquired Hemophilia A: A Case Report.
    Al-Banaa K; Alhillan A; Hawa F; Mahmood R; Zaki A; El Abdallah M; Zimmerman J; Musa F
    Am J Case Rep; 2019 Jul; 20():1046-1048. PubMed ID: 31318850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emicizumab in the Treatment of Acquired Haemophilia: A Case Report.
    Möhnle P; Pekrul I; Spannagl M; Sturm A; Singh D; Dechant C
    Transfus Med Hemother; 2019 Apr; 46(2):121-123. PubMed ID: 31191199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of emicizumab on APTT, one-stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors.
    Bowyer A; Kitchen S; Maclean R
    Haemophilia; 2020 May; 26(3):536-542. PubMed ID: 32249990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
    Fosbury E; Drebes A; Riddell A; Chowdary P
    Ther Adv Hematol; 2017 Sep; 8(9):263-272. PubMed ID: 29051804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET.
    Coppola A; Castaman G; Santoro RC; Mancuso ME; Franchini M; Marino R; Rivolta GF; Santoro C; Zanon E; Sciacovelli L; Manca S; Lubrano R; Golato M; Tripodi A; Rocino A;
    Haemophilia; 2020 Nov; 26(6):937-945. PubMed ID: 33094880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emicizumab: A Review in Haemophilia A.
    Blair HA
    Drugs; 2019 Oct; 79(15):1697-1707. PubMed ID: 31542880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET.
    Castaman G; Santoro C; Coppola A; Mancuso ME; Santoro RC; Bernardini S; Pugliese FR; Lubrano R; Golato M; Tripodi A; Rocino A; Santagostino E; ; Biasoli C; Borchiellini A; Catalano A; Contino L; Coluccia A; Cultrera D; De Cristofaro R; Di Minno G; Fabbri A; Franchini M; Gamba G; Giuffrida AC; Gresele P; Giampaolo A; Hassan HJ; Luciani M; Marchesini E; Marino R; Mazzucconi MG; Molinari AC; Morfini M; Notarangelo LD; Peccarisi L; Peyvandi F; Pollio B; Rivolta GF; Ruggieri MP; Sargentini V; Schiavoni M; Sciacovelli L; Serino ML; Siragusa S; Tagliaferri A; Testa S; Tosetto A; Zampogna S; Zanon E
    Blood Transfus; 2020 Mar; 18(2):143-151. PubMed ID: 31657709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.